Results 21 to 30 of about 4,868 (171)

Outcomes among patients with Staphylococcus aureus bacteremia enrolled in a postdischarge outpatient parenteral antibiotic therapy program at an academic medical center

Antimicrobial Stewardship & Healthcare Epidemiology, 2022
We compared patients with Staphylococcus aureus bacteremia enrolled in outpatient parenteral antibiotic therapy monitoring program (OPAT-MP) upon hospital discharge with patients not enrolled.
Deborah A. Theodore, E. Yoko Furuya, Eloise Austin, William G. Greendyke   +3 more
doaj   +1 more source

Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses

BMJ Open, 2021
Objectives To compare costs associated with different models of outpatient parenteral antimicrobial therapy (OPAT) delivery with costs of inpatient (IP) care across key infection groups managed via OPAT in the UK.Design A cost-minimisation design was ...
Mark Gilchrist, Maria Dimitrova, R A Seaton   +2 more
doaj   +1 more source

Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.

PLoS Medicine, 2015
BackgroundOutpatient parenteral antimicrobial therapy (OPAT) is accepted as safe and effective for medically stable patients to complete intravenous (IV) antibiotics in an outpatient setting.
Kavita P Bhavan, L Steven Brown, Robert W Haley   +2 more
doaj   +1 more source

Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan

International Journal of Infectious Diseases, 2020
Objectives: The infectious diseases team at Kameda Medical Center, Japan, implemented a new outpatient parenteral antimicrobial therapy (OPAT) program in July 2012 and expanded the program with the support of home care services.
Ryota Hase, Yoshiaki Yokoyama, Hiroyuki Suzuki, Shunsuke Uno, Takahiro Mikawa, Daisuke Suzuki, Kiyoharu Muranaka, Naoto Hosokawa   +7 more
doaj   +1 more source

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections

Therapeutic Advances in Infectious Disease, 2022
Introduction: A marked increase in hospitalizations for severe, injection-related infections (SIRI) has been associated with the opioid epidemic. Outpatient parenteral antibiotic therapy (OPAT) is typically not offered to persons with opioid use disorder
Laura C. Fanucchi, Sean M. Murphy, Hilary Surratt, Shashi N. Kapadia, Sharon L. Walsh, James A. Grubbs, Alice C. Thornton, Paul Nuzzo, Michelle R. Lofwall   +8 more
doaj   +1 more source

Safety and clinical outcomes of outpatient parenteral antibiotic therapy for infective endocarditis in Christchurch, New Zealand: A retrospective cohort study

International Journal of Infectious Diseases, 2023
Objectives: We examined the safety and clinical outcomes of outpatient parenteral antibiotic therapy (OPAT) for patients with infective endocarditis (IE) in Christchurch, New Zealand.
Patrick O. Campbell, Kate Gallagher, Simon C. Dalton, Sarah C.L. Metcalf, Nicholas M. Douglas, Stephen T. Chambers   +5 more
doaj   +1 more source

Outcomes of outpatient parenteral antimicrobial therapy (OPAT) for urinary tract infections – A single center retrospective cohort study

Clinical Infection in Practice, 2023
Background: Outpatient parenteral antimicrobial therapy (OPAT) is widely used to safely administer intravenous antibiotics in the outpatient setting. However, there are risks of treatment failure and clinical complications.
Sadia Shakoor, Oyewole Chris Durojaiye, Paul J. Collini   +2 more
doaj   +1 more source

Outpatient parenteral antimicrobial therapy (OPAT) for aortic vascular graft infection; a five-year retrospective evaluation

BMC Infectious Diseases, 2021
Objectives An estimated 1% of endovascular aneurysm repair (EVAR) devices become infected, carrying a high mortality rate. Surgical explantation is recommended and prognosis is guarded. This retrospective cohort analysis focuses on the role of outpatient
Niamh Allen, Mohamed Adam, Grace O’Regan, Aoife Seery, Cora McNally, Samuel McConkey, Aisling Brown, Eoghan de Barra   +7 more
doaj   +1 more source

Outpatient parenteral antibiotic therapy in a renal transplant population: A single-center experience

Saudi Journal of Kidney Diseases and Transplantation, 2015
Outpatient parenteral antimicrobial therapy (OPAT) is a well-established method in medical specialties. Its use in renal transplant recipients has not been thoroughly explored. No guidelines within this patient subset exist.
Jade Harrison, Mohammad Ayaz Hossain, Mohamed Morsy, Abbas Ghazanfar   +3 more
doaj   +1 more source

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy

Therapeutic Advances in Infectious Disease, 2023
Background: Outpatient parenteral antimicrobial therapy (OPAT), when required, is beneficial to patients and healthcare systems by reducing hospital length-of-stay, providing cost savings, and improving patient satisfaction.
Abby C. Bradley, Mary Joyce B. Wingler, Katherine L. Artman, Lori M. Ward, Jose Lucar   +4 more
doaj   +1 more source